Clinical Trial Update: A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating APG-1387 in combination with Entecavir for chronic hepatitis B is ongoing with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbv Infection
• Hepatitis B

Drugs mentioned

• APG-1387 (APG-1387)
• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Hepatitis B, Chronic Hep B | Phase 2 | Status: UNKNOWN